We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-5.8%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$17.9B
AUM Growth
-$2.38B
Cap. Flow
-$772M
Cap. Flow %
-4.31%
Top 10 Hldgs %
23.3%
Holding
1,751
New
15
Increased
221
Reduced
786
Closed
51

Top Buys

Rank Stock Value
1
VRRM icon
Verra Mobility
VRRM
+$34.1M
2
SPGI icon
S&P Global
SPGI
+$22.9M
3
PWR icon
Quanta Services
PWR
+$22M
4
NOVA
Sunnova Energy
NOVA
+$20.8M
5
JCI icon
Johnson Controls International
JCI
+$19.4M

Top Sells

Rank Stock Value
1
LTHM
Livent Corporation
LTHM
+$54.7M
2
IPGP icon
IPG Photonics
IPGP
+$48.9M
3
DAR icon
Darling Ingredients
DAR
+$46.6M
4
NVDA icon
NVIDIA
NVDA
+$45.2M
5
AMZN icon
Amazon
AMZN
+$38.1M

Sector Composition

Rank Sector Weight
1 Technology 24.99%
2 Healthcare 18.87%
3 Consumer Discretionary 13.32%
4 Financials 12.03%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LILAK icon
1676
Liberty Latin America Class C
LILAK
$1.67B
$129K ﹤0.01%
14,758
-11,000
-43% -$105K
GRWG icon
1677
GrowGeneration
GRWG
$105M
$127K ﹤0.01%
13,800
– –
WW
1678
DELISTED
WW International
WW
$123K ﹤0.01%
12,058
– –
DCH
1679
Dauch Corp
DCH
$1.61B
$121K ﹤0.01%
15,546
-2,400
-13% -$20.5K
PRCH icon
1680
Porch Group
PRCH
$1.83B
$117K ﹤0.01%
16,900
– –
ALLO icon
1681
Allogene Therapeutics
ALLO
$714M
$116K ﹤0.01%
12,700
– –
SANA icon
1682
Sana Biotechnology
SANA
$1.13B
$115K ﹤0.01%
13,900
– –
VLDR
1683
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$115K ﹤0.01%
44,800
– –
PGEN icon
1684
Precigen
PGEN
$2.45B
$109K ﹤0.01%
51,504
– –
ZY
1685
DELISTED
Zymergen Inc. Common Stock
ZY
$102K ﹤0.01%
35,300
– –
RXRX icon
1686
Recursion Pharmaceuticals
RXRX
$1.76B
$95K ﹤0.01%
13,300
– –
SDC
1687
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$92K ﹤0.01%
35,600
– –
KLRS
1688
Kalaris Therapeutics
KLRS
$93.8M
$90K ﹤0.01%
583
– –
RUBY
1689
DELISTED
Rubius Therapeutics, Inc
RUBY
$82K ﹤0.01%
14,900
– –
VIEW
1690
DELISTED
View, Inc. Class A Common Stock
VIEW
$77K ﹤0.01%
702
-71,127
-99% -$10.8M
ZYME icon
1691
Zymeworks
ZYME
$1.77B
$75K ﹤0.01%
11,500
– –
KRON
1692
DELISTED
Kronos Bio
KRON
$73K ﹤0.01%
10,100
– –
PRPL icon
1693
Purple Innovation
PRPL
$28.4M
$72K ﹤0.01%
492
– –
SLQT icon
1694
SelectQuote
SLQT
$124M
$72K ﹤0.01%
25,900
– –
ANGI icon
1695
Angi Inc
ANGI
$176M
$65K ﹤0.01%
1,140
– –
VRM icon
1696
Vroom Inc
VRM
$52.1M
$58K ﹤0.01%
273
– –
CZOO
1697
DELISTED
Cazoo Group Ltd
CZOO
$56K ﹤0.01%
10
– –
STTK icon
1698
Shattuck Labs
STTK
$752M
$55K ﹤0.01%
12,800
– –
ALEC icon
1699
Alector
ALEC
$240M
– –
-15,700
Closed -$324K
AMWD
1700
DELISTED
American Woodmark
AMWD
– –
-3,672
Closed -$239K
66 67
68
69 70

Similar funds

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Handelsbanken Fonder's Q1 2022 Portfolio in Review

As of Q1 2022, Handelsbanken Fonder held 1,751 positions worth $17.9B, down 12% from $20.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Handelsbanken Fonder withdrew a net $772M in Q1 2022, closing 51 positions and reducing 786 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Handelsbanken Fonder opened a new position in Johnson Controls International worth $18.5M.

  • Handelsbanken Fonder's largest Q1 2022 buy was Johnson Controls International: 282,551 shares worth $18.5M.
  • Handelsbanken Fonder added most to Verra Mobility in Q1 2022, an estimated $34.1M increase.
  • Handelsbanken Fonder's biggest Q1 2022 reduction was Livent Corporation, cutting an estimated $54.7M.
  • Handelsbanken Fonder fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $13.8M.
  • Handelsbanken Fonder's ten largest holdings make up 23% of its $17.9B portfolio in Q1 2022.
  • Handelsbanken Fonder opened 15 new positions and closed 51 in Q1 2022.
  • Handelsbanken Fonder's portfolio value fell 12% quarter-over-quarter to $17.9B.

Based on Handelsbanken Fonder's 13F filing for Q1 2022, filed 11 May 2022.